SynthesisEndocrine2024

Efficacy and safety of BRAF/MEK inhibitors in BRAFV600E-mutated anaplastic thyroid cancer: a systematic review and meta-analysis.

Jonathan N Priantti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.